Unknown

Dataset Information

Acupuncture for Bortezomib-Induced Peripheral Neuropathy: Not Just for Pain.


ABSTRACT:

Background

Bortezomib-induced peripheral neuropathy (BIPN) is a common and debilitating side effect. Our pilot study demonstrated that acupuncture is safe and can decrease total neuropathic symptoms. However, there is lack of knowledge in which individual BIPN symptoms benefited from acupuncture.

Purpose

To characterize individual symptoms reduced by acupuncture in patients with BIPN.

Methods

Patients with multiple myeloma treated with bortezomib who developed BIPN grade 2 or above, based on National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE), were enrolled and received 10 acupuncture treatments over 10 weeks. Self-reported BIPN-associated symptoms assessments were collected weekly at baseline, during, and after acupuncture treatment u

SUBMITTER: Zhi WI 

PROVIDER: S-EPMC6247555 | biostudies-literature | 2018 Dec

REPOSITORIES: biostudies-literature